Moderate to Severe Psoriasis, Hardcover by Koo, John Y. M., M.D. (EDT); Levin...
중등도 및 중증 건선, 하드커버, Koo, John Y. M., M.D. (EDT); Levin 저
| 상품번호 | 389947339694 |
| 상태 | Like New |
| 거래유형 | 즉시구매 |
| 출고국 | 미국 (US) |
이베이 판매가
$195.63
약 288,359원
구매대행 예상 비용은 로그인 후 확인하실 수 있습니다.
상품 설명
Moderate to Severe Psoriasis, Hardcover by Koo, John Y. M., . (EDT); Levin, Ethan C., . (EDT); Leon, Argentina, . (EDT); Wu, Jashin J., . (EDT); Gottlieb, Alice B., ., . (EDT), ISBN 1482215160, ISBN-13 9781482215168, Like New Used, Free shipping in the US
This 23-chapter volume details the use of biologics and other pharmacologic and phototherapy treatments for moderate to severe psoriasis. Dermatologists from the US and Canada also cover clinical manifestations, genetics, pathophysiology, factors affecting remissions and flares, therapy strategy, counseling and education, psychological intervention, patient evaluation, topical agents, combination therapy, systemic therapy, and special considerations like psoriatic arthritis, pediatric psoriasis, the immunomodulatory/immunosuppressive classification system, and the risk of systemic immunosuppression. This edition has new chapters on day treatment programs, new agents, erythrodermic pustular psoriasis, special populations, pharmacogenetics, and biologic fatigue. Annotation ©2014 Ringgold, Inc., Portland, OR ()
This 23-chapter volume details the use of biologics and other pharmacologic and phototherapy treatments for moderate to severe psoriasis. Dermatologists from the US and Canada also cover clinical manifestations, genetics, pathophysiology, factors affecting remissions and flares, therapy strategy, counseling and education, psychological intervention, patient evaluation, topical agents, combination therapy, systemic therapy, and special considerations like psoriatic arthritis, pediatric psoriasis, the immunomodulatory/immunosuppressive classification system, and the risk of systemic immunosuppression. This edition has new chapters on day treatment programs, new agents, erythrodermic pustular psoriasis, special populations, pharmacogenetics, and biologic fatigue. Annotation ©2014 Ringgold, Inc., Portland, OR ()